Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance

Model for Mitigation of Workplace Transmission of COVID-19 Through Population-Based Testing and Surveillance

Authors: Plantes PJ, Fragala MS, Clarke C, Goldberg ZN, Radcliff J, Goldberg SE.

Citation: Popul Health Manag. 2021 Jan 25. doi: 10.1089/pop.2020.0322. Online ahead of print.

Specialties: Infectious Disease, COVID-19, Population health

Download key summary

Related content

Publication
Association of SARS-CoV-2 Seropositive Antibody Test With Risk of Future Infection
Publication
Estimated SARS-CoV-2 antibody seroprevalence trends and relationship to reported case prevalence from a repeated, cross-sectional study in the 50 states and the District of Columbia, United States-October 25, 2020-February 26, 2022
Publication
Performance of Unobserved Self-collected Nasal Swabs for Detection of SARS-CoV-2 by RT-PCR Utilizing a Remote Specimen Collection Strategy.

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.